Covered recipient · General Payments record
TOMIA E HARMON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018
$244.68
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $244.68 | 16 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $50.51 | 3 |
| Novo Nordisk AS | $47.17 | 3 |
| Lilly USA, LLC | $26.43 | 2 |
| Radius Health, Inc. | $17.87 | 1 |
| Acerta Pharma LLC | $17.21 | 1 |
| SANOFI-AVENTIS U.S. LLC | $17.00 | 1 |
| PFIZER INC. | $15.67 | 1 |
| Phadia US Inc. | $14.88 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $13.82 | 1 |
| ABBVIE INC. | $12.18 | 1 |
| Merck Sharp & Dohme Corporation | $11.94 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $244.68 | 16 |
Payment records · PY2018 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie, Inc. | $12.18 | 06/13/2018 | Food and Beverage | Undisputed | 01/23/2026 | 570921395 | CMS |
| Amgen Inc. | $18.87 | 04/26/2018 | Food and Beverage | Undisputed | 01/23/2026 | 568596551 | CMS |
| Amgen Inc. | $12.11 | 06/06/2018 | Food and Beverage | Undisputed | 01/23/2026 | 568596560 | CMS |
| Amgen Inc. | $19.53 | 10/04/2018 | Food and Beverage | Undisputed | 01/23/2026 | 568596573 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.21 | 06/21/2018 | Food and Beverage | Undisputed | 01/23/2026 | 559979323 | CMS |
| Lilly USA, LLC | $13.88 | 04/11/2018 | Food and Beverage | Undisputed | 01/23/2026 | 559874167 | CMS |
| Lilly USA, LLC | $12.55 | 08/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | 559874177 | CMS |
| Merck Sharp & Dohme Corporation | $11.94 | 03/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | 604280471 | CMS |
| Novartis Pharmaceuticals Corporation | $13.82 | 05/22/2018 | Food and Beverage | Undisputed | 01/23/2026 | 608198367 | CMS |
| Novo Nordisk Inc | $15.17 | 05/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587892899 | CMS |
| Novo Nordisk Inc | $16.50 | 07/19/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587892895 | CMS |
| Novo Nordisk Inc | $15.50 | 09/25/2018 | Food and Beverage | Undisputed | 01/23/2026 | 587892897 | CMS |
| PFIZER INC. | $15.67 | 02/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | 610045501 | CMS |
| Phadia US Inc. | $14.88 | 09/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | 590562671 | CMS |
| Radius Health, Inc. | $17.87 | 08/28/2018 | Food and Beverage | Undisputed | 01/23/2026 | 615422247 | CMS |
| SANOFI-AVENTIS U.S. LLC | $17.00 | 09/11/2018 | Food and Beverage | Undisputed | 01/23/2026 | 602788507 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.